Search results
Results from the WOW.Com Content Network
In the early 2000s QLT USA developed Aczone, a 5% dapsone gel that was shown to be effective against acne without causing clinically significant declines in hemoglobin levels, even in subjects with G6PD deficiency. [64] In February 2016, the FDA approved a 7.5% dapsone gel.